Ads
related to: multiple myeloma- Contact a Representative
For Questions and Information
About This Treatment
- Primary and Subgroup Data
Primary- and Subgroup-
Specific Data
- Phase 3 Trial
Explore the Phase 3 Trial Design,
Results, and Patient Population
- Patient Profile
Potential Treatment Candidates
HCPs, See Who May Be Appropriate
- Contact a Representative
Search results
Metastatic multiple myeloma: Symptoms, treatment, and more
Medical News Today· 6 days agoMetastatic multiple myeloma is a form of cancer of the bone marrow that has spread to other parts of...
Multiple myeloma: Prognosis by age
Medical News Today· 6 days agoStatistics regarding multiple myeloma (MM) show that the survival rates are lower for older adults. This may stem from a combination of biological...
Press Release: Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible...
Benzinga· 3 days agoLicense Application (sBLA) for the investigational use of Sarclisa (isatuximab) in combination with bortezomib, lenalidomide and dexamethasone (VRd) for the treatment of patients with transplant-ineligible ...
Sanofi's (SNY) Sarclisa sBLA Gets FDA's Priority Review Tag
Zacks via Yahoo Finance· 2 days agoThe FDA grants priority review to Sanofi's (SNY) sBLA for the Sarclisa combination regimen for...
Quadruple Therapies and the Future of Multiple Mye | Newswise
Newswise· 7 days agoMIAMI, FLORIDA – The treatment landscape for multiple myeloma, the second most common blood cancer,...
Top 10 most common cancers among Blacks
Rolling Out· 7 hours agoUnderstanding the most common cancers among African Americans is crucial for improving prevention, early detection, and treatment strategies.
Earnings call: BioLineRx Q1 2024 results show steady progress By Investing.com
Investing.com· 15 hours agoBioLineRx (BLRX) has reported its financial results for the first quarter of 2024, highlighting...
UH offers outpatient bone marrow transplants
News Channel 5 Cleveland· 7 days agoUniversity Hospitals is offering outpatient bone marrow transplants for Multiple Myeloma patients. Multiple Myeloma
Military chiefs 'knew about helicopter cancer risk', claim ex-servicemen
Daily Express· 17 hours agoPersonnel who travelled in Wessex, Puma, Chinook and Sea King helicopters have developed a range of...
Small Business - Austin Daily Herald | Austin Daily Herald
Austin Daily Herald· 5 hours agoSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today
Ads
related to: multiple myeloma
